- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Zai Lab (Shanghai) Co., Ltd.
Total 1502 results
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingSolid Tumors
-
Shanghai Gopherwood Biotech Co., Ltd.RecruitingAdvanced Solid TumorChina
-
Shanghai Vinnerna Biosciences Co., Ltd.RecruitingCOVID-19 PatientChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Shanghai YingLi Pharmaceutical Co. Ltd.RecruitingAdvanced Solid TumorsChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromeChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Clear Cell Renal Cell Carcinoma
-
Shanghai YingLi Pharmaceutical Co. Ltd.Not yet recruitingAdvanced Solid Tumor
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Etern BioPharma (Shanghai) Co., LtdRecruiting
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingIntrahepatic CholangiocarcinomaChina
-
RetroLead (Shanghai) BioPharma Co., Ltd.Not yet recruitingHuman Immunodeficiency Virus-1 (HIV-1) Infection
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Shanghai EpimAb Biotherapeutics Co., Ltd.RecruitingAdvanced Solid TumorAustralia, China
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingHER2-positive Advanced Solid TumorsChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingGastric or Esophagogastric Junction AdenocarcinomaChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.RecruitingPatients With Advanced Solid TumorsChina
-
Shanghai Pharmaceuticals Holding Co., LtdRecruitingSarcoma, EwingChina
-
Shanghai WD Pharmaceutical Co., Ltd.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
Mabwell (Shanghai) Bioscience Co., Ltd.Recruiting
-
Shanghai Bovax Biotechnology Co., Ltd.RecruitingCervical Cancer | Vulvar Cancer | Vaginal Cancer | CIN1 | CIN2 | CIN3 | VaIN1 | VaIN2 | VaIN3 | Genital Wart | VIN 1 | VIN 2 | VIN 3 | AISChina
-
Shanghai Junshi Bioscience Co., Ltd.Not yet recruitingMelanoma | Breast Cancer | Lung CanceChina
-
Ocumension Therapeutics (Shanghai) Co., LtdCompleted
-
Shanghai EpimAb Biotherapeutics Co., Ltd.TerminatedAdvanced Solid TumorsChina, Australia, United States
-
Shanghai Pharmaceuticals Holding Co., LtdCompleted
-
Shanghai Biomabs Pharmaceutical Co., Ltd.CompletedWet Age-related Macular DegenerationChina
-
Genrix (Shanghai) Biopharmaceutical Co., Ltd.Completed
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Active, not recruitingTotal Knee ArthroplastyChina
-
Shanghai Huaota Biopharmaceutical Co., Ltd.Completed
-
Shanghai Jiatan Pharmatech Co., LtdEnrolling by invitationRifampicin-resistant TuberculosisChina
-
Mabwell (Shanghai) Bioscience Co., Ltd.CompletedAsthma | Atopic Dermatitis | COPDChina
-
Shanghai HEP Pharmaceutical Co., Ltd.WithdrawnType 2 Diabetes Patients
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Enrolling by invitation
-
Shanghai Jiatan Pharmatech Co., LtdCompletedPIK3CA Mutation-Related TumorsChina
-
Shanghai NewMed Medical Co., Ltd.Active, not recruiting
-
Shanghai Vinnerna Biosciences Co., Ltd.Active, not recruitingThe Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese SubjectsChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingAdvanced Hepatocellular Carcinoma (HCC)China, Singapore
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Completed
-
Shanghai Bovax Biotechnology Co., Ltd.TerminatedCervical Cancer | CIN1 | CIN2 | CIN3 | Genital Wart | AIS | Vain I | Vain III | Vin I | Vin II | Vin III | VAIN - Vaginal Intraepithelial Neoplasia 2China
-
Shanghai YingLi Pharmaceutical Co. Ltd.Enrolling by invitationAdvanced Solid TumorChina
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingStage II-III Non-small Cell Lung CancerChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Active, not recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Active, not recruitingPrimary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1China